Flor Navarro
Overview
Explore the profile of Flor Navarro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martin-Otal C, Sanchez-Moreno I, Gomez-Moron A, Castro C, Casares N, Navarro F, et al.
J Immunother Cancer
. 2025 Feb;
13(2).
PMID: 39988346
Background: Phosphatidylserine (PS) exposed on apoptotic cells promotes immune clearance of dead cells without inducing inflammation. Conversely, PS exposure on live tumor cells promotes an immunosuppressive tumor microenvironment that hinders...
2.
Sanchez-Moreno I, Lasarte-Cia A, Martin-Otal C, Casares N, Navarro F, Gorraiz M, et al.
J Immunother Cancer
. 2024 Jul;
12(7).
PMID: 38955421
Background: Adoptive cell therapy using genetically modified T cells to express chimeric antigen receptors (CAR-T) has shown encouraging results, particularly in certain blood cancers. Nevertheless, over 40% of B cell...
3.
Reparaz D, Casares N, Fuentes A, Navarro F
Methods Cell Biol
. 2024 Mar;
185:79-97.
PMID: 38556453
Hepatocellular carcinoma (HCC) is one of the most prevalent malignant neoplasms. Current treatments for HCC, such as tyrosine kinase inhibitors, have limited efficacy, highlighting the urgent need for better therapies....
4.
Casares N, Alfaro M, Cuadrado-Tejedor M, Lasarte-Cia A, Navarro F, Vivas I, et al.
Front Immunol
. 2023 May;
14:1130044.
PMID: 37187754
A complex network of interactions exists between the olfactory, immune and central nervous systems. In this work we intend to investigate this connection through the use of an immunostimulatory odorant...
5.
Reparaz D, Ruiz M, Silva L, Aparicio B, Egea J, Guruceaga E, et al.
Front Immunol
. 2022 Oct;
13:991311.
PMID: 36300124
Vaccination using optimized strategies may increase response rates to immune checkpoint inhibitors (ICI) in some tumors. To enhance vaccine potency and improve thus responses to ICI, we analyzed the gene...
6.
Reparaz D, Hommel M, Navarro F, Llopiz D
Int Rev Cell Mol Biol
. 2022 Aug;
371:1-14.
PMID: 35964997
Dendritic cells (DCs) are professional antigen presenting cells that play an important role in the induction of T cell responses. Different subsets (cDC1s, cDC2s, pDCs, and moDCs) were described based...
7.
Martin-Otal C, Lasarte-Cia A, Serrano D, Casares N, Conde E, Navarro F, et al.
J Immunother Cancer
. 2022 Aug;
10(8).
PMID: 35918123
Background: One of the main difficulties of adoptive cell therapies with chimeric antigen receptor (CAR)-T cells in solid tumors is the identification of specific target antigens. The tumor microenvironment can...
8.
Martin-Otal C, Navarro F, Casares N, Lasarte-Cia A, Sanchez-Moreno I, Hervas-Stubbs S, et al.
Int Rev Cell Mol Biol
. 2022 Jul;
370:1-31.
PMID: 35798502
Recent advances in immunotherapy have revolutionized the treatment of cancer. The use of adoptive cell therapies (ACT) such as those based on tumor infiltrating lymphocytes (TILs) or genetically modified cells...
9.
Navarro F, Casares N, Martin-Otal C, Lasarte-Cia A, Gorraiz M, Sarrion P, et al.
Oncoimmunology
. 2022 May;
11(1):2070337.
PMID: 35529677
The high metabolic activity and insufficient perfusion of tumors leads to the acidification of the tumor microenvironment (TME) that may inhibit the antitumor T cell activity. We found that pharmacological...
10.
Lozano T, Conde E, Martin-Otal C, Navarro F, Lasarte-Cia A, Nasrallah R, et al.
Cancer Lett
. 2022 Jan;
528:45-58.
PMID: 34973390
Adoptive cell transfer therapy using CD8 T lymphocytes showed promising results eradicating metastatic malignancies. However, several regulatory mechanisms limit its efficacy. We studied the role of the expression of the...